HF
GILD icon

HRT Financial’s Gilead Sciences GILD Stock Holding History

HRT Financial’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-270,699
Closed -$35.7M – 4638
2026
Q1 		$37.7M Buy
+270,699
New +$37.9M 0.09% 179
2025
Q4 		– Sell
-104,670
Closed -$12.7M – 3478
2025
Q3 		$11.6M Buy
+104,670
New +$11.9M 0.04% 342
2025
Q2 		– Sell
-1,310,726
Closed -$139M – 2966
2025
Q1 		$147M Buy
+1,310,726
New +$135M 0.93% 10
2024
Q4 		– Sell
-1,224,351
Closed -$110M – 2690
2024
Q3 		$103M Buy
+1,224,351
New +$93.4M 0.51% 18
2024
Q2 		– Sell
-59,779
Closed -$4.38M – 2515
2024
Q1 		$4.38M Buy
+59,779
New +$4.6M 0.03% 299
2023
Q4 		– Sell
-4,584
Closed -$357K – 2590
2023
Q3 		$343K Buy
+4,584
New +$353K ﹤0.01% 1598
2023
Q2 		– Sell
-290,798
Closed -$24.1M – 2744
2023
Q1 		$24.1M Sell
290,798
-5,617
-2% -$465K 0.29% 50
2022
Q4 		$25.4M Buy
+296,415
New +$23.5M 0.36% 39
2022
Q2 		– Sell
-61,019
Closed -$3.78M – 3200
2022
Q1 		$3.63M Buy
+61,019
New +$3.9M 0.03% 383
2021
Q1 		– Sell
-87,227
Closed -$5.62M – 2847
2020
Q4 		$5.08M Buy
+87,227
New +$5.26M 0.1% 150
2020
Q3 		– Sell
-41,716
Closed -$2.89M – 2055
2020
Q2 		$3.21M Buy
+41,716
New +$3.2M 0.1% 219
2019
Q4 		– Sell
-17,839
Closed -$1.13M – 1332
2019
Q3 		$1.13M Sell
17,839
-75,159
-81% -$4.91M 0.05% 325
2019
Q2 		$6.28M Buy
+92,998
New +$6.12M 0.4% 57
2015
Q4 		– Sell
-3,716
Closed -$364K – 85
2015
Q3 		$364K Buy
+3,716
New +$413K 0.31% 44

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

HRT Financial's GILD Position: Q2 2026 in Review

HRT Financial sold out of Gilead Sciences (GILD) in Q2 2026, closing a stake of 270,699 shares — an estimated $35.7M sold.

HRT Financial first reported a position in GILD in Q3 2015 and held it in 14 quarters. The position peaked at $147M in Q1 2025. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • HRT Financial reported no remaining Gilead Sciences position as of Q2 2026 after selling out during the quarter.
  • HRT Financial sold 270,699 Gilead Sciences shares in Q2 2026, an estimated $35.7M.
  • HRT Financial first reported a position in Gilead Sciences in Q3 2015 and held it in 14 quarters.
  • HRT Financial's Gilead Sciences position peaked at $147M in Q1 2025.
  • 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.